This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Itamar Medical Ltd.
Itamar Medical Ltd., a pioneering name in the medical technology sector, is headquartered in Israel (IL) and operates extensively across global markets. Founded in 1997, the company has established itself as a leader in the development of innovative solutions for sleep and cardiovascular disorders. Itamar Medical is renowned for its flagship product, WatchPAT, a unique home sleep apnea testing device that combines advanced technology with user-friendly design, setting it apart in the industry. The company’s commitment to enhancing patient care and improving diagnostic accuracy has earned it a prominent position in the healthcare landscape. With a focus on non-invasive monitoring solutions, Itamar Medical continues to achieve significant milestones, contributing to advancements in sleep medicine and cardiovascular health.
DitchCarbon Score
How does Itamar Medical Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Itamar Medical Ltd.'s score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Itamar Medical Ltd., headquartered in Israel (IL), currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Asahi Kasei Corporation, which may influence its climate commitments and reporting practices. Asahi Kasei Corporation, the parent company, has established various climate initiatives, but specific reduction targets or achievements for Itamar Medical Ltd. have not been disclosed. The absence of documented reduction targets or climate pledges indicates that Itamar Medical Ltd. may still be in the early stages of formalising its sustainability strategy. Given the lack of direct emissions data and specific commitments from Itamar Medical Ltd., it is essential to monitor future disclosures for any developments in their carbon emissions reporting and climate action initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | 0,000,000,000 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | - | 0,000,000,000 | - | - | - | - | - | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Itamar Medical Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
